NCT01671943已完成不适用
Evaluation of Safety and Feasibility of ICE-SENSE3TM , a Cryotherapy Device for Office-based Ultrasound- Guided Treatment of Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 4
- 试验地点
- 1
- 主要终点
- The rate of complete tumor ablation in patients treated with cryoablation, with complete tumor ablation defined as no remaining invasive or in-situ carcinoma present upon pathological examination of the surgical resection specimen
研究概览
简要总结
The purpose of this study is to evaluate the clinical feasibility and safety of the ICESENSE3TM cryotherapy system for the ablation of small malignant invasive breast tumors.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Unifocal primary invasive ductal breast carcinoma diagnosed by core needle biopsy. Patients with contralateral disease will remain eligible. Note: Results of ER, PR, HER-2/neu must be obtained on pre-registration needle core biopsy material.
- •Tumor size ≤ 2.0 cm in greatest diameter as measured by breast ultrasound, MRI and mammogram. The largest dimension measured will be used to determine eligibility.
- •Tumor enhancement on MRI
- •Tumor with <25% intraductal components in the aggregate.
- •Non-pregnant and non-lactating patients. Patients of childbearing potential must have a negative serum or urine pregnancy test. NOTE: Peri-menopausal women must be amenorrheic for > 12 months to be considered not of childbearing potential.
- •Adequate breast size for safe cryoablation. Patients with breasts too small to allow safe cryoablation are not eligible as the minimal thickness of the breast tissue does not lend itself to cryoablation. NOTE: The minimal distance of tumor margins from the breast skin should be analogous to the surgical margins of a lumpectomy.
排除标准
- •Patients with multifocal and/or multicentric ipsilateral breast cancer, multifocal calcifications, or evidence of excessive DCIS.
- •History of rotational vacuum assisted core biopsies, en bloc open surgical biopsy and/or lumpectomy for diagnosis/treatment of the index breast cancer.
- •Prior or planned neoadjuvant chemotherapy for breast cancer.
- •Patients with thrombocytopenia and or any other coagulation abnormality
结局指标
主要结局
The rate of complete tumor ablation in patients treated with cryoablation, with complete tumor ablation defined as no remaining invasive or in-situ carcinoma present upon pathological examination of the surgical resection specimen
时间窗: One month
次要结局
- Pain assessment(One month)
- Adverse events(One month)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
ICE-SENSE™ Cryotherapy for Breast Fibroadenoma TrialFibroadenomaNCT00910312IceCure Medical Ltd.54
已完成
不适用
A CLinical Study to Evaluate the Safety And Effectiveness of the CeRene DevIce to Treat HeavY Menstrual BleedingMenorrhagiaNCT02842736Channel Medsystems242
进行中（未招募）
不适用
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical PracticeCoronary DiseaseCoronary Artery DiseaseNCT03967158Seung-Jung Park2,000
已完成
不适用
Clinical Validation Study of the Eximis CS (Contained Segmentation) SystemLaparoscopic Gynecological Surgical ProceduresNCT06572163Eximis Surgical23
进行中（未招募）
不适用
Cryoanalgesia for the Treatment of Pain in Subjects With Morton's NeuromaMorton's NeuromaPain ManagementNCT05604144Northern California Research Trials, Inc.5